| Literature DB >> 30382821 |
Yun Qian1, Qixin Han2,3, Wenjun Liu4,5, Wei-En Yuan6, Cunyi Fan7,8.
Abstract
BACKGROUND: China had the third highest burden of tuberculosis population in the world. Bone and joint tuberculosis was a major part and its characteristics were rarely discussed before. This study was designed to review the characteristics and management of bone and joint tuberculosis among native and migrant population in Shanghai, China during 2011-2015.Entities:
Keywords: Anti-tuberculosis; Bone and joint tuberculosis; Migrant; Native; Shanghai; Surgery
Mesh:
Year: 2018 PMID: 30382821 PMCID: PMC6211459 DOI: 10.1186/s12879-018-3456-3
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Schematic structure of patient enrollment
Fig. 2The map showing the study area and sample size
Demographic information of bone and joint tuberculosis patients from 2011 to 2015 in Shanghai
| Demographic information | Native people | Migrant people | |
|---|---|---|---|
| Patients | 54 | 61 | / |
| Male/female | 37/17 | 42/19 | 0.969 |
| Age | 55.89(25–83) | 46.84(16–85) | 0.003a |
| Recurrent(Alive) | 5(9.80%) | 9(16.67%) | 0.009b |
| Dead | 1(1.96%) | 4(7.41%) | |
| Cured | 45(88.24%) | 41(75.93%) |
aMan whitney U test
bFischer Exact test
Clinical evaluation of bone and joint tuberculosis patients from 2011 to 2015 in Shanghai
| Clinical features | Native people | Migrant people | |||
|---|---|---|---|---|---|
| Duration of symptom onset to hospital | 5.63(1–72) | 8.57(1–36) | 0.007a | ||
| Symptom | Pain | 50(92.59%) | 58(95.08%) | 0.705b | |
| Night sweat | 15(27.78%) | 12(19.67%) | 0.306 | ||
| Fever | 24(44.44%) | 25(40.98%) | 0.708 | ||
| Cough | 7(12.96%) | 11(18.03%) | 0.455 | ||
| Weight loss | 12(22.22%) | 10(16.39%) | 0.428 | ||
| Paraplegia | 3(5.56%) | 9(14.75%) | 0.107 | ||
| Limitations in activity | 23(42.59%) | 19(31.15%) | 0.203 | ||
| Laboratory exam | Neutrophils (%) | 61.57(39.10–79.40) | 62.40(42.40–79.60) | 0.659 | |
| ESR(mm/h) | 17.51(7.60–25.90) | 16.75(7.50–25.20) | 0.346 | ||
| CRP(mg/l) | 13.57(9.22–20.22) | 13.13(8.45–21.23) | 0.358a | ||
| Hemoglobin(g/l) | 111.98(86–143) | 112.89(80–139) | 0.733 | ||
| T-SPOT | 24(64.86%) | 25(44.64%) | 0.056 | ||
| Sputum culture | 31(73.81%) | 35(71.43%) | 0.800 | ||
| Biopsies | 0 | 2 | / | ||
| Radiological exam | Chest | negative | 24(44.44%) | 32(52.46%) | 0.442 |
| moderate | 23(42.59%) | 19(31.15%) | |||
| severe | 7(12.96%) | 10(16.39%) | |||
| Joint | negative | 0 | 0 | 0.031 | |
| moderate | 33(61.11%) | 25(40.98%) | |||
| severe | 21(38.89%) | 36(59.02%) | |||
| Infection site | Peripheral | Shoulder | 3(5.56%) | 4(6.56%) | 0.639 |
| Elbow | 3(5.56%) | 3(4.92%) | |||
| Wrist | 1(1.85%) | 1(1.64%) | |||
| Hip | 4(7.41%) | 6(9.84%) | |||
| Knee | 8(14.81%) | 3(4.92%) | |||
| Ankle/foot | 3(5.56%) | 1(1.64%) | |||
| Spine | Cervical | 7(12.96%) | 9(14.75%) | 0.649 | |
| Thoracic | 8(14.81%) | 16(26.23%) | |||
| Lumbar | 16(29.63%) | 16(26.23%) | |||
| Paravertebral abscess | 1(1.85%) | 2(3.28%) | |||
| Concomitant TB | Pulmonary | 22(40.74%) | 27(44.26%) | 0.888 | |
| Lymph nodes | 2(3.70%) | 3(4.92%) | |||
| Urinary tract and kidney | 2(3.70%) | 5(8.20%) | |||
| Comorbidity | HT | 22(40.74%) | 10(16.39%) | 0.004 | |
| DM | 21(38.89%) | 8(13.11%) | 0.001 | ||
| RA | 6(11.11%) | 5(8.20%) | 0.596 | ||
| HIV | 3(5.56%) | 3(4.92%) | 1.000 | ||
| Syphilis | 3(5.56%) | 2(3.28%) | 0.664 | ||
| Previous TB | 5(9.26%) | 7(11.48%) | 0.698 | ||
| Cancer | 17(31.48%) | 9(14.75%) | 0.032 | ||
| Drug resistant pattern | Isoniazid | 14(25.93%) | 18(29.51%) | 0.669c | |
| Rifampin | 8(14.81%) | 11(18.03%) | 0.643c | ||
| Ethambutol | 6(11.11%) | 8(13.11%) | 0.743c | ||
| Streptomycin | 10(18.52%) | 11(18.03%) | 0.946c | ||
| Multidrug resistance | 0 | 2(3.28%) | 0.497b | ||
| Surgical intervention | 34(62.96%) | 32(52.46%) | 0.256 | ||
| Infection | 5(9.26%) | 8(13.11%) | 0.515 | ||
| Drug | 40(74.08%) | 46(75.41%) | 0.869 | ||
| Mean time for anti-tuberculosis treatment | 8.96(6–12) d1 | 7.94(4–12) d2 | 0.003 | ||
| Follow-up duration | 15.16(12–24)d1 | 13.63(12–23)d2 | 0.011a | ||
ESR erythrocyte sedimentation rate, CRP C-reactive protein, HT hypertension, DM diabetes mellitus, RA rheumatoid arthritis, HIV Human Immunodeficiency Virus, TB tuberculosis
aMann Whitney U test
bFischer Exact test
cPearson chi square test
d13 patients were lost in the follow-up
d27 patients were lost in the follow-up
Fig. 3X-ray of pulmonary tuberculosis. a Moderate infection; b Severe infection
Fig. 4X-ray, CT and MR of different peripheral bone and joint tuberculosis. a X-ray of shoulder TB; b X-ray of hip TB; c X-ray of elbow TB; d MR of shoulder TB; e CT of elbow TB
Fig. 5CT and MR of spine tuberculosis. a CT of spine TB: anterioposterior position; b CT of spine TB: lateral position; c MR of spine TB